Baxter International Inc.
BAX Healthcare Medical Instruments & Supplies
Baxter International Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.2 billion, up 5.72% from fiscal 2024. In the quarter to June 2026, revenue grew 5.34%, EPS grew 33.3%, free cash flow grew 119.5% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years.
Follow BAX
Baxter International Inc. (BAX) Operating cash flow
Baxter International Inc.'s operating cash flow for fiscal 2025 was $845.0M, down 17.1% from $1.0B in fiscal 2024. Over the twelve months to 30 June 2026 it was $1.3B. Over the past ten years it has ranged from $845.0M (fiscal 2025) to $2.2B (fiscal 2021) — the current reading is the lowest in ten years. Baxter International Inc. ranks 6th of 54 Medical Instruments & Supplies companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $845.0M | (17.08%) |
| FY2024 | $1.0B | (40.96%) |
| FY2023 | $1.7B | 42.53% |
| FY2022 | $1.2B | (45.50%) |
| FY2021 | $2.2B | 18.95% |
| FY2020 | $1.9B | (11.22%) |
| FY2019 | $2.1B | 4.31% |
| FY2018 | $2.0B | 17.68% |
| FY2017 | $1.7B | 3.63% |
| FY2016 | $1.7B | (6.61%) |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Jun 2026 | $285.0M | 33.80% |
| Mar 2026 | $213.0M | (63.53%) |
| Dec 2025 | $584.0M | 146.41% |
| Sep 2025 | $237.0M | 9.22% |
| 42 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| BAX Baxter International Inc. | $1.3B |
| COO The Cooper Companies, Inc. compare | $1.0B |
| ALGN Align Technology, Inc. compare | $755.7M |
| WST West Pharmaceutical Services, Inc. compare | $662.2M |
| AVTR Avantor, Inc. compare | $597.0M |
| ATR AptarGroup, Inc. compare | $583.5M |
| BLCO Bausch + Lomb Corporation compare | $458.0M |
| SOLV Solventum Corporation compare | $209.0M |
| RGEN Repligen Corporation compare | $134.9M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on BAX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement